Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,566 | -5,335 | -2,774 | -335 | -319 |
| Depreciation Amortization | 445 | 2,246 | 1,663 | 1,088 | 528 |
| Accounts receivable | -1,099 | 1,308 | 1,377 | 434 | 158 |
| Accounts payable and accrued liabilities | 424 | 2,465 | 1,430 | 1,737 | -331 |
| Other Working Capital | -2,725 | 4,243 | 4,219 | 1,341 | -879 |
| Other Operating Activity | 1,530 | -955 | -1,251 | -1,174 | 648 |
| Operating Cash Flow | $-3,991 | $3,972 | $4,664 | $3,091 | $-195 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -668 | -2,872 | -2,112 | -1,358 | -754 |
| Investing Cash Flow | $-668 | $-2,872 | $-2,112 | $-1,358 | $-754 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12 | 85 | 86 | 86 | N/A |
| Common Stock Repurchased | -602 | -74 | N/A | N/A | N/A |
| Financing Cash Flow | $-590 | $11 | $86 | $86 | $N/A |
| Beginning Cash Position | 10,118 | 9,007 | 9,007 | 9,007 | 9,007 |
| End Cash Position | 4,869 | 10,118 | 11,645 | 10,826 | 8,058 |
| Net Cash Flow | $-5,249 | $1,111 | $2,638 | $1,819 | $-949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,991 | 3,972 | 4,664 | 3,091 | -195 |
| Capital Expenditure | -668 | -2,872 | -2,112 | -1,358 | -754 |
| Free Cash Flow | -4,659 | 1,100 | 2,552 | 1,733 | -949 |